National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
Contains
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

imiquimod  Patient Information
A synthetic agent with immune response modifying activity. As an immune response modifier (IRM), imiquimod stimulates cytokine production, especially interferon production, and exhibits antitumor activity, particularly against cutaneous cancers. Imiquimod's proapoptotic activity appears to be related to Bcl-2 overexpression in susceptible tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
US brand name:Aldara
Abbreviation:IMQ
Code names:R 837
S 26308
Chemical structure names:
  • 1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-
  • 4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov